Healthcare Sector

BLCO

Market Tracker

$17.24
-0.13
(-0.75%)
8:00 pm
Next Earnings: (est.) 08/02/23 12:00 am
  • BLCO (Selected)

    Bausch + Lomb Corporation

BLCO Support / Resistance Levels

Loading Data..
WhaleStream

15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.

BLCO Most Active Options Strike Prices Whale BUY Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.

BLCO Most Active Options Strike Prices Whale SALES Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.

BLCO Dark Pool and Public Equity Key Price Levels

Loading Data..

Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.

BLCO Open Interest Trend

Loading Data..

Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.

BLCO Largest 1-Day Open Interest Movements

Expires Type Strike OI Change Percent
02/21/2025 CALL $20.00 4,467 +937 +26.54%
01/17/2025 CALL $20.00 2,692 +454 +20.29%
05/16/2025 CALL $17.50 698 +175 +33.46%
05/16/2025 CALL $20.00 624 +73 +13.25%
02/21/2025 CALL $15.00 149 +19 +14.62%
05/16/2025 PUT $25.00 13 +4 +44.44%
12/19/2025 PUT $30.00 0 0
12/19/2025 PUT $35.00 0 0
01/17/2025 CALL $12.50 14 -3 -17.65%
02/21/2025 CALL $17.50 589 -3 -0.51%
01/17/2025 CALL $17.50 105 -18 -14.63%
01/17/2025 CALL $15.00 68 -19 -21.84%

Contracts with largest changes in open interest from the previous trading day to the current/most recent.

BLCO Major Holders

Name Pct Held Shares Total
Blackrock Funds-Health Sciences Opportunity Portfolio 0.36% 1.27M 24.86M
Fidelity Strategic Advisors Small-Mid Cap Fund 0.22% 778.24k 15.25M
Northern Lights Fd Tr II-Invenomic Fd 0.20% 711.4k 13.94M
BlackRock Health Sciences Trust II 0.15% 523.55k 10.26M
Franklin Mutual Series Fund-Mutual Quest Fund 0.13% 467.51k 9.16M
First Trust U.S. Equity Opportunities ETF 0.06% 213.89k 4.19M
JNL Series Trust-JNL/Multi Manager Small Cap Value Fund 0.05% 164.34k 3.22M
Professionally Managed Portf-Hodges Small Cap Fund 0.04% 150k 2.94M
AMG Managers River Road Small Mid Cap Value Fund 0.04% 127.14k 2.49M
JP Morgan ETF Tr-BetaBuilders Canada ETF 0.04% 125.53k 2.46M

BLCO News

  • Ophthalmic Drugs Global Market Report 2025: Innovations in Retinal Disorders, Glaucoma Drive Global Ophthalmic Medicines Surge

    01/13 05:46 am

    GlobeNewswire Inc.

    Read more
  • Implantable Drug Delivery Devices Business Research Report 2023-2024 & 2030 - Rising Focus on Biocompatible and Biodegradable Implantable Devices

    01/08 12:57 pm

    GlobeNewswire Inc.

    Read more
  • Aesthetic Ophthalmology Devices Business Analysis Report 2024-2030 Featuring 40+ Key Players Including Abbott, Bausch & Lomb, Alcon, Allergan, Carl Zeiss, Haag Streit, Meditec, Topcon, Zeimer

    12/23 11:59 am

    GlobeNewswire Inc.

    Read more
  • Ophthalmic Lasers Market, Competitive Landscape and Market Forecasts to 2030

    12/16 12:52 pm

    GlobeNewswire Inc.

    Read more
  • Deal Dispatch: Altus Power, Motorsport Games Explore Options, True Value Goes Bankrupt, M&A Activity Lags

    10/21 02:46 pm

    Benzinga

    Read more
  • Why Bausch + Lomb Stock Soared by Over 7% on Monday

    10/14 06:40 pm

    The Motley Fool

    Read more
  • Bausch & Lomb And Edgewise Therapeutics Are Among Top 7 Mid Cap Stock Gainers Last Week (Sept 15-Sept 21): Are The Others In Your Portfolio?

    09/22 05:34 pm

    Benzinga

    Read more
  • Helsinn Group appoints Riccardo Carbucicchio to the Board of Directors

    09/19 08:00 am

    GlobeNewswire Inc.

    Read more
  • Why Bausch + Lomb Rallied Today

    09/16 03:31 pm

    The Motley Fool

    Read more
  • Contact Lens Supplier Bausch + Lomb Eyes Sale Amid Separation Challenges As Parent Bausch Health Faces Debt Issues

    09/16 01:22 pm

    Benzinga

    Read more
  • Milestone Pharmaceuticals Appoints Industry Veteran Joseph Papa to its Board of Directors

    09/04 08:00 am

    GlobeNewswire Inc.

    Read more
  • Bausch + Lomb (BLCO) Reports Q2 Earnings: What Key Metrics Have to Say

    07/31 09:30 am

    Zacks Investment Research

    Read more
  • Nicox announces attendance at upcoming conferences - GlobeNewswire

    07/19 01:31 am

    GlobeNewswire Inc.

    Read more
  • Nicox appoints experienced biotech leader Damian Marron as Chair of the Board and Marc Le Bozec as Director - GlobeNewswire

    07/16 01:31 am

    GlobeNewswire Inc.

    Read more
  • India Vision Care Market Predicted to Witness Substantial Growth Through 2030 - GlobeNewswire

    07/03 10:50 am

    GlobeNewswire Inc.

    Read more
  • Global Colored Contact Lenses Market Size To Worth USD 9.82 Billion By 2033 | CAGR Of 7.67% - GlobeNewswire

    07/03 10:02 am

    GlobeNewswire Inc.

    Read more
  • Why Is Clearside Biomedical Stock Gaining Today?

    06/25 12:54 pm

    Benzinga

    Read more
  • American Airlines To Rally Around 59%? Here Are 10 Top Analyst Forecasts For Monday

    05/06 07:56 am

    Benzinga

    Read more
  • Earnings Preview: Alignment Healthcare (ALHC) Q1 Earnings Expected to Decline

    04/25 10:01 am

    Zacks Investment Research

    Read more
  • Analysts Estimate Bausch + Lomb (BLCO) to Report a Decline in Earnings: What to Look Out for

    04/24 10:01 am

    Zacks Investment Research

    Read more
  • BLCO vs. AVTR: Which Stock Is the Better Value Option?

    04/08 11:40 am

    Zacks Investment Research

    Read more
  • All You Need to Know About Bausch + Lomb (BLCO) Rating Upgrade to Buy

    03/25 12:00 pm

    Zacks Investment Research

    Read more
  • BLCO or AVTR: Which Is the Better Value Stock Right Now?

    03/21 11:40 am

    Zacks Investment Research

    Read more
  • BLCO or AVTR: Which Is the Better Value Stock Right Now?

    03/21 10:41 am

    Zacks Investment Research

    Read more
  • Surging Earnings Estimates Signal Upside for Bausch + Lomb (BLCO) Stock

    03/20 12:20 pm

    Zacks Investment Research

    Read more
  • Tracking Carl Icahn's 13F Report - Q4 2023 Update

    03/04 03:15 am

    Seeking Alpha

    Read more
  • Barclays Maintains Equal-Weight Rating for Bausch & Lomb: Here's What You Need To Know

    02/26 01:00 pm

    Benzinga

    Read more
  • Why International Flavors & Fragrances Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

    02/21 02:50 pm

    Benzinga

    Read more
  • Bausch & Lomb’s stock soars 9% after earnings beat

    02/21 12:18 pm

    MarketWatch

    Read more
  • Toll Brothers Posts Upbeat Earnings, Joins Exelon, Garmin, Bausch + Lomb And Other Big Stocks Moving Higher On Wednesday

    02/21 11:47 am

    Benzinga

    Read more
  • Compared to Estimates, Bausch + Lomb (BLCO) Q4 Earnings: A Look at Key Metrics

    02/21 10:30 am

    Zacks Investment Research

    Read more
  • Wall Street Waits With Bated Breath For Nvidia Earnings After Tech Selloff, Fed Minutes Eyed: Analyst Flags This As Biggest Risk For Market

    02/21 07:51 am

    Benzinga

    Read more
  • Seeking Clues to Bausch + Lomb (BLCO) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics

    02/15 10:15 am

    Zacks Investment Research

    Read more
  • Will Bausch + Lomb (BLCO) Beat Estimates Again in Its Next Earnings Report?

    02/14 01:10 pm

    Zacks Investment Research

    Read more
  • Bausch + Lomb (BLCO) Expected to Beat Earnings Estimates: Should You Buy?

    02/14 11:00 am

    Zacks Investment Research

    Read more
  • Earnings Preview: What To Expect To When Eye Health Company Bausch + Lomb Reports Q4 Performance Later This Month

    02/09 03:24 pm

    Benzinga

    Read more
  • The Latest Analyst Ratings for Bausch & Lomb

    12/04 09:00 am

    Benzinga

    Read more
  • Alcon stock falls as third-quarter sales miss estimates

    11/15 09:49 am

    MarketWatch

    Read more
  • Stocks Edge Higher Ahead Of Federal Reserve Decision, Bonds Surge After Softer Treasury Refunding Plan: What's Driving Markets Wednesday?

    11/01 01:23 pm

    Benzinga

    Read more
  • Bausch + Lomb (BLCO) Reports Q3 Earnings: What Key Metrics Have to Say

    11/01 09:30 am

    Zacks Investment Research

    Read more
  • Apple, AMD, Palantir Earnings On Deck This Week As Market Seeks Positive Catalysts In Fed Decision Week

    10/30 03:40 am

    Benzinga

    Read more
  • Analysts Estimate Organon (OGN) to Report a Decline in Earnings: What to Look Out for

    10/26 10:02 am

    Zacks Investment Research

    Read more
  • Bausch + Lomb (BLCO) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

    10/25 10:02 am

    Zacks Investment Research

    Read more
  • Aldeyra (ALDX) Plummets on Dry Eye Disease Drug's Setback

    10/17 10:13 am

    Zacks Investment Research

    Read more
  • Novartis (NVS) Spins off Sandoz, Reiterates Annual Outlook

    10/04 11:47 am

    Zacks Investment Research

    Read more
  • 6 Analysts Have This to Say About Bausch & Lomb

    10/03 12:00 pm

    Benzinga

    Read more
  • Novartis (NVS) Announces Positive Data on Kidney Disease Drug

    10/03 11:50 am

    Zacks Investment Research

    Read more
  • Is the Options Market Predicting a Spike in Bausch + Lomb (BLCO) Stock?

    09/19 08:32 am

    Zacks Investment Research

    Read more
👀

Follow the Whales in real-time.

🎁

Take 50% OFF With Code: